These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 9931138)

  • 1. Afferent arteriolar vasodilation to the sulfonimide analog of 11, 12-epoxyeicosatrienoic acid involves protein kinase A.
    Imig JD; Inscho EW; Deichmann PC; Reddy KM; Falck JR
    Hypertension; 1999 Jan; 33(1 Pt 2):408-13. PubMed ID: 9931138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Actions of epoxygenase metabolites on the preglomerular vasculature.
    Imig JD; Navar LG; Roman RJ; Reddy KK; Falck JR
    J Am Soc Nephrol; 1996 Nov; 7(11):2364-70. PubMed ID: 8959626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuronal nitric oxide synthase-dependent afferent arteriolar function in angiotensin II-induced hypertension.
    Ichihara A; Imig JD; Navar LG
    Hypertension; 1999 Jan; 33(1 Pt 2):462-6. PubMed ID: 9931148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium mobilization contributes to pressure-mediated afferent arteriolar vasoconstriction.
    Inscho EW; Cook AK; Mui V; Imig JD
    Hypertension; 1998 Jan; 31(1 Pt 2):421-8. PubMed ID: 9453339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epoxygenase metabolites contribute to nitric oxide-independent afferent arteriolar vasodilation in response to bradykinin.
    Imig JD; Falck JR; Wei S; Capdevila JH
    J Vasc Res; 2001; 38(3):247-55. PubMed ID: 11399897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochrome P450 and cyclooxygenase metabolites contribute to the endothelin-1 afferent arteriolar vasoconstrictor and calcium responses.
    Imig JD; Pham BT; LeBlanc EA; Reddy KM; Falck JR; Inscho EW
    Hypertension; 2000 Jan; 35(1 Pt 2):307-12. PubMed ID: 10642316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complex interactions of NO/cGMP/PKG systems on Ca2+ signaling in afferent arteriolar vascular smooth muscle.
    Fellner SK; Arendshorst WJ
    Am J Physiol Heart Circ Physiol; 2010 Jan; 298(1):H144-51. PubMed ID: 19880669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced renal microvascular reactivity to angiotensin II in hypertension is ameliorated by the sulfonimide analog of 11,12-epoxyeicosatrienoic acid.
    Imig JD; Zhao X; Falck JR; Wei S; Capdevila JH
    J Hypertens; 2001 May; 19(5):983-92. PubMed ID: 11393683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal arteriolar angiotensin responses during varied adenosine receptor activation.
    Carmines PK; Inscho EW
    Hypertension; 1994 Jan; 23(1 Suppl):I114-9. PubMed ID: 8282342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoregulation of afferent arteriolar blood flow in juxtamedullary nephrons.
    Takenaka T; Harrison-Bernard LM; Inscho EW; Carmines PK; Navar LG
    Am J Physiol; 1994 Nov; 267(5 Pt 2):F879-87. PubMed ID: 7977792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between endogenously produced carbon monoxide and nitric oxide in regulation of renal afferent arterioles.
    Botros FT; Navar LG
    Am J Physiol Heart Circ Physiol; 2006 Dec; 291(6):H2772-8. PubMed ID: 16844915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Afferent arteriolar dilation to 11, 12-EET analogs involves PP2A activity and Ca2+-activated K+ Channels.
    Imig JD; Dimitropoulou C; Reddy DS; White RE; Falck JR
    Microcirculation; 2008 Feb; 15(2):137-50. PubMed ID: 18260004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nebivolol-induced vasodilation of renal afferent arterioles involves β3-adrenergic receptor and nitric oxide synthase activation.
    Feng MG; Prieto MC; Navar LG
    Am J Physiol Renal Physiol; 2012 Sep; 303(5):F775-82. PubMed ID: 22674024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of epithelial sodium channel blockade on the myogenic response of rat juxtamedullary afferent arterioles.
    Guan Z; Pollock JS; Cook AK; Hobbs JL; Inscho EW
    Hypertension; 2009 Nov; 54(5):1062-9. PubMed ID: 19720952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of selective inhibition of soluble guanylyl cyclase on the K(Ca) channel activity in coronary artery smooth muscle.
    Li PL; Jin MW; Campbell WB
    Hypertension; 1998 Jan; 31(1 Pt 2):303-8. PubMed ID: 9453320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine2A receptor vasodilation of rat preglomerular microvessels is mediated by EETs that activate the cAMP/PKA pathway.
    Carroll MA; Doumad AB; Li J; Cheng MK; Falck JR; McGiff JC
    Am J Physiol Renal Physiol; 2006 Jul; 291(1):F155-61. PubMed ID: 16478979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of adenosine A1 and A2a receptors on renal microvascular reactivity.
    Nishiyama A; Inscho EW; Navar LG
    Am J Physiol Renal Physiol; 2001 Mar; 280(3):F406-14. PubMed ID: 11181402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Afferent arteriolar vasodilator effect of adenosine predominantly involves adenosine A2B receptor activation.
    Feng MG; Navar LG
    Am J Physiol Renal Physiol; 2010 Aug; 299(2):F310-5. PubMed ID: 20462966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of cyclo-oxygenase blockade on juxtamedullary microvascular responses to angiotensin II in rat kidney.
    Harrison-Bernard LM; Carmines PK
    Clin Exp Pharmacol Physiol; 1995 Oct; 22(10):732-8. PubMed ID: 8575109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. cGMP-dependent and not cAMP-dependent kinase is required for adenosine-induced dilation of intracerebral arterioles.
    West GA; Meno JR; Nguyen TS; Ngai AC; Simard JM; Winn HR
    J Cardiovasc Pharmacol; 2003 Mar; 41(3):444-51. PubMed ID: 12605023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.